Search

Ondek plans oral vaccine

Despite some initial setbacks, Nobel Prize winner and medical research scientist Professor Barry Marshall is making inroads after some early setbacks with his spin-off company, Ondek Pty Ltd, which plans to licence an oral vaccine delivery system developed from Professor Marshall’s research into stomach ulcer bacterium.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Included in the following lists:

BNiQ Disclaimer